EMA Authorised: Gotenfia (golimumab) — Stada Arzneimittel AG

View source ↗

Summary

European Medicines Agency authorised Gotenfia (golimumab) by Stada Arzneimittel AG for multiple inflammatory diseases including various forms of arthritis and u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis
• Juvenile Idiopathic Arthritis
• Non-radiographic Axial Spondyloarthritis
• Psoriatic Arthritis
• Rheumatoid Arthritis
• Ulcerative Colitis

Drugs mentioned

• Gotenfia (golimumab)

Snippet

Status: Authorised. Therapeutic area: Arthritis, Rheumatoid;Arthritis, Juvenile;Arthritis, Psoriatic;Axial Spondyloarthritis;Non-Radiographic Axial Spondyloarthritis;Colitis, Ulcerative. MAH: Stada Arzneimittel AG. Decision date: 19/06/2026